Other
2030
Amgen 2030 decreased by 4.3% to $2.20B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.20B to $2.20B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
A stable or declining schedule of amortization supports long-term margin expansion.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2030. It provides a m...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_4a0a03Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.20B | $2.20B | $1.70B | $1.70B | $1.80B | $2.10B | $2.10B | $2.10B | $2.90B | $2.90B | $2.90B | $2.20B | $2.30B | $2.30B | $2.20B |
| QoQ Change | — | +0.0% | -22.7% | +0.0% | +5.9% | +16.7% | +0.0% | +0.0% | +38.1% | +0.0% | +0.0% | -24.1% | +4.5% | +0.0% | -4.3% |
| YoY Change | — | — | — | -22.7% | -18.2% | +23.5% | +23.5% | +16.7% | +38.1% | +38.1% | +38.1% | -24.1% | -20.7% | -20.7% | +0.0% |
Range$1.70B – $2.90B
CAGR+0.0%
Avg YoY Growth+6.0%
Median YoY Growth+8.3%
2030 at Other Companies
Frequently Asked Questions
- What is Amgen's 2030?
- Amgen (AMGN) reported 2030 of $2.20B in Q1 2026.
- How has Amgen's 2030 changed year-over-year?
- Amgen's 2030 decreased by 0.0% year-over-year, from $2.20B to $2.20B.
- What does 2030 mean?
- The expected non-cash expense for acquired intangible assets in the year 2030.